Join the club for FREE to access the whole archive and other member benefits.

Underdog Pharmaceuticals

Company developing simple and direct interventions targeting toxic forms of cholesterol for age-related diseases.

Underdog Pharmaceuticals, Inc., is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.

Underdog was built from an SRF flagship program that has driven two years of applied development designed to explore and repair the underlying causes of cardiovascular disease. Its co-founders are Matthew O’Connor, Ph.D., and Michael Kope, formerly the Vice President of Research and the founding Chief Executive Officer, respectively, of SRF. 

Visit website: https://underdogpharma.com/

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

See also: Institute SENS Research Foundation - Non-profit organization focused on transforming the way the world researches and treats age-related diseases

People at Underdog Pharmaceuticals

Company Representative

Co-Chief Executive Officer and Co-founder Underdog Pharmaceuticals

Company Representative

Co-Chief Executive Officer and Co-founder of Underdog Pharmaceuticals.

Underdog Pharmaceuticals News

Underdog pharmaceuticals secures $10m funding from Kizoo ventures

Longevity Technology - 23-Sep-2021

Funds to bring affordable and effective age-related therapies to the public

Read more...

'Innovation Passport' awarded for Underdog's novel compound intended for treating heart diseases

Longevity Technology - 09-Sep-2021

Safe and potential compound shows disease-modifying effect by removing toxic cholesterol from blood

Read more...

Two drug molecules delivered via nanoparticles to combat atherosclerosis

Lifespan.io (LEAF) - 26-Jun-2020

Success in mice model gives hope for fighting cholesterol-associated inflammatory diseases

Read more...

Fight Aging! reports back from SENS Research Foundation Pitch Day

Fight Aging! - 20-Jan-2020

When some of these succeed in human trials even more money will pile in to fund further advances

Read more...